Romain Paro

Worked in the corporate drug safety department of an international laboratory. Responsible of the preparation of all the safety reports to the Health Authorities (Periodic Safety Update Reports, Annual Safety Reports, FDA Report). Managed the international cases reported with medical analysis in the causality (French method of Imputability), the seriousness, and the listedness until the ICSR sent. Reconciliation of safety database and clinical database. Designed request for specific safety concerns.

Worked in the French affiliate group as the French responsible of the pharmacovigilance. Reported all safety concerns to the corporate. Trained the new employee in pharmacovigilance.

Worked in the medical management division of a lobbying, public affairs, and strategic advisory office. Served as a liaison between ADC and its affiliated laboratories. Represented ADC in meetings with customers. Developed a method in analysis of scientific literature that improved in-office efficiency. Active member of the Health and Eco-Strategy Consulting Cabinet as a writer of the Pricing and reimbursement files.

Managed scientific committees composed of physicians and experts in the cardiovascular and respiratory fields. Conducted pharmacoepidemiological and pharmaceuticoeconomics studies in the cardiovascular and respiratory fields while working in the Health Outcome Studies Section (EES) of the Economic and Governmental Affairs Department. Successfully achieved a study protocol answering to the French Economic Committee on Drugs (CEPS). Monitored the positioning of cardiovascular and respiratory pharmaceutical-epidemiologic studies.

Independently conducted investigation targeting thirty Risk Management Plans (RMP) while working for the National Department of Risk Monitoring, Ethical Use of and Information on Drugs (SURBUM). Produced pharmacovigilance reports for the EMEA working party. Served as the liaison between two French Public Authorities for post-launch drugs studies.

Worked in the pharmacoepidemiology unit. Managed a research study on the economic incidence of gastro-intestinal side effects of the use of NSAIDs. Successfully improved my English communication.